BioTech Health XJuly 20, 2022 Biotech NewsMerck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial 3 minute read Today Merck & Co. (NYSE: MRK) announced that Keytruda has failed the Phase 3 clinical trial KEYNOTE-412 evaluating… 4 Shares 4 0 0 0 0 0 0
BioTech Health XJuly 27, 2021 Biotech NewsRecent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data 9 minute read A recent report published by the American Association for Cancer Research titled Subgroup Analyses in Oncology Trials: Regulatory… 0 Shares 0 0 0 0 0 0 0